These results suggest that concurrent activation of LXR and PPARα as a strategy to control glucose and lipid metabolism in obesity is beneficial but could lead to elevation of lipid accumulation in the liver. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.